title: Bone: osteoporosis therapy--time to consider renal function.
authors: Bone and Mineral Research Unit, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, Hospital Universitario Central de Asturias, C/ Julián Clavería, s/n 33006 Oviedo, Spain. cannata@hca.es
authors: Jorge B
authors: JB
authors: Cannata-Andía
authors: Carlos
authors: C
authors: Gómez-Alonso
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic / Q000379:methods*; D000069448:Denosumab; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000503:physiopathology*; D007677:Kidney Function Tests / Q000379:methods; D010024:Osteoporosis / Q000188:drug therapy* / Q000378:metabolism; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069448:Denosumab